07.24.2023
Prevent & Delay
$278,978.00
24 months
Cost-effectiveness of Public Health Screening for Pre-symptomatic Type 1 Diabetes with and without Treatment for Prevention of Type 1 Diabetes
Funds support cost-effectiveness assessments of T1D screening and clinical monitoring with or without disease-modifying treatment, compared to routine care.